You are here

Article Text

Article menu

Download PDFPDF

XML
Hemorrhagic Stroke
Original research
Treatment of recurrent aneurysms using the Woven EndoBridge (WEB): anatomical and clinical results
  1. Matthias Gawlitza1,
  2. Sebastien Soize1,
  3. Anne-Christine Januel2,
  4. Cristian Mihalea3,
  5. Georgios-Emmanouil Metaxas1,
  6. Christophe Cognard2,
  7. Laurent Pierot1
  1. 1 Service de Neuroradiologie, Hôpital Maison Blanche, CHU de Reims, Reims, France
  2. 2 Service de Neuroradiologie Diagnostique et Thérapeutique, Hôpital Purpan, CHU de Toulouse, Toulouse, France
  3. 3 Service de Neuroradiologie Interventionnelle, NEURI, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
  1. Correspondence to Professor Laurent Pierot, Department of Neuroradiology, Hôpital Maison Blanche CHU, Reims 51100, France; lpierot{at}gmail.com

Abstract

Background The safety and efficacy of the Woven EndoBridge (WEB) for the treatment of naïve intracranial aneurysms has been confirmed.

Purpose To analyze the safety and efficacy of the WEB in the treatment of recurrent aneurysms.

Methods Anatomical and clinical results in consecutive patients with a recurrent aneurysm, who were treated using the WEB device in two French neurointerventional centers, were evaluated.

Results Seventeen patients with 17 aneurysms were included. Treatment was feasible in 16 patients. In seven patients (41.2%), ancillary devices were used. Permanent morbidity due to a thromboembolic complication occurred in one patient (5.9%). There was no mortality. Follow-up angiographic studies were available for 15 patients after a mean of 12.1±6.1 months. Rates of complete occlusion, neck remnant, and aneurysm remnant were 33.3%, 40.0%, and 26.7%, respectively.

Conclusions Treatment of recurrent aneurysms using the WEB device may be reasonably safe and effective.

  • aneurysm
  • device
  • intervention
  • technique
  • material

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/neurintsurg-2017-013287

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors MG: Substantial contributions to the conception or design of the work; acquisition, analysis and interpretation of data; drafting the work; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. SS, ACJ, G-EM, CC, LP: Substantial contributions to the conception or design of the work; acquisition, analysis and interpretation of data for the work; revising the work critically for important intellectual content; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. CM: Analysis and interpretation of data.

    • Competing interests CC: Consultancy of Sequent Medical, MicroVention, Stryker and Codman. LP: Consultancy of Sequent Medical, MicroVention, Neuravi, Penumbra, Balt.

    • Ethics approval This study was performed after approval of the local institutional review board and owing to its retrospective design, informed consent was waived.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Correction notice Since this article was first published online first its open access status has been removed.